Stocks in the news: Lupin, Biocon, PNB, Lauras Labs, PTC India and SJVN
The USFDA has issued 8 observations for the drug product facility and API facility at Mandideep. The US drug regulator has inspected company’s Mandideep unit-1 facility during November 14-23, 2022.
